Der Orthopäde

, Volume 48, Issue 9, pp 784–791 | Cite as

Efficacy of platelet-rich plasma injections for treating Achilles tendonitis

Systematic review of high-quality randomized controlled trials
  • Yuzhong Wang
  • Changxu Han
  • Jianghui Hao
  • Yizhong RenEmail author
  • Jihong WangEmail author



The Achilles tendon is the coarsest tendon in the body. Achilles tendonitis is relatively common and its incidence is increasing.


To evaluate the efficacy of platelet-rich plasma (PRP) injections for treating Achilles tendonitis.


A literature search was carried out in the Cochrane Library Central Register of Controlled Trials (2017), PubMed (January 1976–March 2017) and EMBASE (January 1976–March 2017) databases to retrieve the available clinical evidence for PRP in the treatment of Achilles tendon lesions for a systematic review. The inclusion criteria were (1) conservative PRP treatment of Achilles tendon inflammation in a randomized controlled trial (RCT), (2) level I clinical research evidence and (3) published in English. The exclusion criteria were (1) unclear experimental methods and data and (2) PRP treatment of other diseases.


A total of 4 articles involving 152 cases were included in the analysis. The mean age of subjects was 49 years. Data on the Victorian Institute of Sport Assessment-Achilles (VISA-A) score, color Doppler ultrasound index and recovery time to normal exercise were extracted. There were no significant differences between the treatment groups and control groups following the PRP injections.


The lack of differences between data from the control group and the patient groups included in the studies may be related to the difficulty of performing a randomized controlled trial (RCT). A strong basis for using PRP to treat Achilles tendonitis was not found, although PRP has important clinical significance for treating Achilles tendonitis.


Meta-analysis Vascular endothelial growth factor Regeneration Color Doppler ultrasonography Fibroblasts 



Body mass index


5-Dimension questionnaire


Insulin-like growth factor


Platelet-derived growth factor


Platelet-rich plasma


Randomized controlled trial


Transforming growth factor beta


Vascular endothelial growth factor


Victorian Institute of Sport Assessment-Achilles score

Wirksamkeit von Injektionen mit „platelet-rich plasma“ zur Behandlung einer Achillessehnenentzündung

Systematischer Review von qualitativ hochwertigen randomisierten kontrollierten Studien



Die Achillessehne ist die stärkste Sehne des Körpers. Eine Achillessehnenentzündung ist relativ häufig, mit steigender Inzidenz.


Die Wirksamkeit von Injektionen mit „platelet-rich plasma“ zur Behandlung einer Achillessehnenentzündung wird evaluiert.


Eine Literaturrecherche wurde in den Datenbanken Cochrane Library Central Register of Controlled Trials (2017), PubMed (Januar 1976 bis März 2017) und EMBASE (Januar 1976 bis März 2017) durchgeführt, um die verfügbare klinische Evidenz für PRP zur Behandlung von Achillessehnenläsionen für einen systematischen Review zu erhalten. Die Einschlusskriterien waren (1) konservative PRP-Behandlung einer Achillessehnenentzündung in einer randomisierten kontrollierten Studie (RCT), (2) Level-I-Evidenz der klinischen Studie und (3) Publikation in englischer Sprache. Die Ausschlusskriterien waren (1) unklare experimentelle Methoden und Daten sowie (2) PRP-Behandlung anderer Erkrankungen.


Es wurden 4 Artikel mit insgesamt 152 Fällen in die Analyse eingeschlossen. Das mittlere Patientenalter lag bei 49 Jahren. Daten zum Score des Victorian Institute of Sport Assessment-Achilles (VISA-A), Farbdoppler-Sonographie-Index und zur Heilungsdauer bis zur Ausführung normaler Bewegungen wurden extrahiert. Es gab keine signifikanten Unterschiede zwischen den Behandlungsgruppen und den Kontrollgruppen nach PRP-Injektionen.


Der Mangel an Unterschieden zwischen den Daten der Kontroll- und Patientengruppen, die in die Studien eingeschlossen wurden, kann mit der schwierigen Durchführung einer randomisierten kontrollierten Studie (RCT) zusammenhängen. Eine haltbare Grundlage für die Verwendung von PRP zur Behandlung einer Achillessehnenentzündung wurde nicht gefunden, obwohl PRP einen signifikanten klinischen Vorteil bei der Therapie einer Achillessehnenentzündung zeigt.


Metaanalyse Vaskulärer endothelialer Wachstumsfaktor Regeneration Farbdoppler-Sonographie Fibroblasten 



This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Compliance with ethical guidelines

Conflict of interest

Y. Wang, C. Han, J. Hao, Y. Ren and J. Wang declare that they have no competing interests.

This article does not contain any studies with human participants or animals performed by any of the authors.


  1. 1.
    Vos RJ, Weir A, Schie HT et al (2010) Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA 303:144–149. CrossRefGoogle Scholar
  2. 2.
    Tschon M, Fini M, Giardino R et al (2011) Lights and shadows concerning platelet products for musculoskeletal regeneration. Front Biosci (Elite Ed) 3:96–107Google Scholar
  3. 3.
    Lyras DN, Kazakos K, Georgiadis G et al (2011) Does a single application of PRP alter the expression of IGF-I in the early phase of tendon healing? J Foot Ankle Surg 50(3):276–282CrossRefGoogle Scholar
  4. 4.
    Schnabel LV, Mohammed HO, Miller BJ et al (2007) Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 25(2):230–240CrossRefGoogle Scholar
  5. 5.
    Boswell SG, Cole BJ, Sundman EA et al (2012) Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy 28(3):429–439CrossRefGoogle Scholar
  6. 6.
    de Mos M, van der Windt AE, Jahr H, van Schie HTM, Weinans H et al (2008) Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med 36(6):1171–1178CrossRefGoogle Scholar
  7. 7.
    Kajikawa Y, Morihara T, Sakamoto H et al (2010) Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol 215(3):837–845CrossRefGoogle Scholar
  8. 8.
    Lyras DN, Kazakos K, Verettas D et al (2009) The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing. Foot Ankle Int 30(11):1101–1106CrossRefGoogle Scholar
  9. 9.
    Torricelli P, Fini M, Filardo G et al (2011) Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop 35(10):1569–1576CrossRefGoogle Scholar
  10. 10.
    Lopez-Vidriero E, Goulding KA, Simon DA et al (2010) The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy 26(2):269–278CrossRefGoogle Scholar
  11. 11.
    McCarrel T, Fortier L (2009) Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res 27(8):1033–1042CrossRefGoogle Scholar
  12. 12.
    Cole BJ, Seroyer ST, Filardo G et al (2010) Platelet-rich plasma: where are we now and where are we going? Sports Health 2(3):203–210CrossRefGoogle Scholar
  13. 13.
    Kon E, Filardo G, Martino AD et al (2011) Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc 19(4):516CrossRefGoogle Scholar
  14. 14.
    Vannini F, Di Matteo B, Filardo G et al (2014) Platelet-rich plasma for foot and ankle pathologies: a systematic review. Foot Ankle Surg 20(1):2–9CrossRefGoogle Scholar
  15. 15.
    Filardo G, Presti ML, Kon E et al (2010) Nonoperative biological treatment approach for partial Achilles tendon lesion. Orthopedics 33(2):120–123CrossRefGoogle Scholar
  16. 16.
    Engebretsen L, Steffen K, Alsousou J et al (2010) IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med 44(15):1072–1081CrossRefGoogle Scholar
  17. 17.
    Filardo G, Matteo D et al (2013) Platelet-rich plasma for the treatment of patellar tendinopathy: clinical and imaging findings at medium-term follow-up. Int Orthop 37(8):1583–1589CrossRefGoogle Scholar
  18. 18.
    Sanchez M, Fiz N, Azofra J et al (2012) A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy 28(8):1070–1078CrossRefGoogle Scholar
  19. 19.
    Filardo G, Kon E, Di Martino A et al (2012) Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord 13:229CrossRefGoogle Scholar
  20. 20.
    Cerza F, Carni S, Carcangiu A et al (2012) Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med 40(12):2822–2827CrossRefGoogle Scholar
  21. 21.
    Sobhani S, Dekker R, Postema K et al (2013) Epidemiology of ankle and foot overuse injuries in sports: a systematic review. Scand J Med Sci Sports 23(6):669–686CrossRefGoogle Scholar
  22. 22.
    Kujala UM, Sarna S, Kaprio J (2005) Cumulative incidence of achilles tendon rupture and tendinopathy in male former elite athletes. Clin J Sport Med 15(3):133–135CrossRefGoogle Scholar
  23. 23.
    Cook JL, Khan KM, Harcourt PR et al (1997) A cross sectional study of 100 athletes with jumper’s knee managed conservatively and surgically. The Victorian Institute of Sport Tendon Study Group. Br J Sports Med 31(4):332–336CrossRefGoogle Scholar
  24. 24.
    de Jonge S, de Vos RJ, Weir A et al (2011) One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med 39(8):1623–1629CrossRefGoogle Scholar
  25. 25.
    Krogh TP, Ellingsen T, Christensen R et al (2016) Ultrasound-guided injection therapy of Achilles tendinopathy with platelet-rich plasma or saline: a randomized, blinded, placebo-controlled trial. Am J Sports Med 44(8):1990–1997CrossRefGoogle Scholar
  26. 26.
    de Vos RJ, Weir A, van Schie HT et al (2010) Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA 303(2):144–149CrossRefGoogle Scholar
  27. 27.
    Kearney RS, Parsons N, Costa ML (2013) Achilles tendinopathy management: a pilot randomised controlled trial comparing platelet-richplasma injection with an eccentric loading programme. Bone Joint Res 2(10):227–232CrossRefGoogle Scholar
  28. 28.
    Samiric T (2009) Changes in the composition of the extracellular matrix in patellar tendinopathy. Matrix Biol 28(4):230–236CrossRefGoogle Scholar
  29. 29.
    Lawlor DK, Derose G, Harris KA et al (2011) The role of platelet-rich plasma in inguinal wound healing in vascular surgery patients. Vasc Endovascular Surg 45(3):241–245CrossRefGoogle Scholar
  30. 30.
    Boesen AP, Hansen R, Boesen MI et al (2017) Effect of high-volume injection, platelet-rich plasma, and sham treatment in chronic midportion Achilles tendinopathy: a randomized double-blinded prospective study. Am J Sports Med. Google Scholar
  31. 31.
    Dragoo JL, Wasterlain AS, Braun HJ et al (2012) Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Arthroscopy 28(6):e31–e32Google Scholar
  32. 32.
    Di Matteo B, Filardo G, Kon E et al (2015) Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy—a systematic review. Musculoskelet Surg 99(1):1–9CrossRefGoogle Scholar
  33. 33.
    Moraes VY, Lenza M, Tamaoki MJ et al (2014) Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev. Google Scholar
  34. 34.
    Murawski CD, Smyth NA, Newman H et al (2014) A single platelet-rich plasma injection for chronic midsubstance achilles tendinopathy: a retrospective preliminary analysis. Foot Ankle Spec 7(5):372–376CrossRefGoogle Scholar
  35. 35.
    Lin MT, Chiang CF, Wu CH et al (2018) Meta-analysis comparing autologous blood-derived products (including platelet-rich plasma) injection versus placebo in patients with Achilles tendinopathy. Arthroscopy 34(6):1966CrossRefGoogle Scholar
  36. 36.
    Zhang YJ, Xu SZ, Gu PC et al (2018) Is platelet-rich plasma injection effective for chronic Achilles tendinopathy? A meta-analysis. Clin Orthop Relat Res. Google Scholar
  37. 37.
    Sundman EA, Cole BJ, Fortier LA (2011) Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med 39(10):2135–2140CrossRefGoogle Scholar
  38. 38.
    Harrison S, Vavken P, Kevy S et al (2011) Platelet activation by collagen provides sustained release of anabolic cytokines. Am J Sports Med 39(4):729–734CrossRefGoogle Scholar
  39. 39.
    Bosch G, Moleman M, Barneveld A et al (2011) The effect of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions. Scand J Med Sci Sports 21(4):554–561CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Hand-foot and Microsurgery 2, The 2nd affiliated HospitalInner Mongolia Medical UniversityHyumin District, HohhotChina
  2. 2.Department of Arthroscopy and Sports Medicine, The 2nd affiliated HospitalInner Mongolia Medical UniversityHyumin District, HohhotChina
  3. 3.Department of Neurology, The Second HospitalHebei Medical UniversityXinhua District, ShijiazhuangChina
  4. 4.Department of OrthopedicsHebei Chest HospitalShijiazhuangChina

Personalised recommendations